LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF THE GO-RAISE TRIAL

被引：0

作者：

Deodhar, A. ^{[1
]}

Braun, J. ^{[2
]}

Inman, R. ^{[3
]}

van der Heijde, D. ^{[4
]}

Zhou, Y. ^{[5
]}

Hsu, B. ^{[5
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany

[3] Univ Toronto, Toronto, ON, Canada

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Janssen R&D LLC, Spring House, PA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：283 / 284

页数：2

共 50 条

[1] LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF A RANDOMIZED, PLACEBO- CONTROLLED TRIAL
Deodhar, Atul
Braun, Jurgen
Inman, Robert
van der Heijde, Desiree
Zhou, Yiying
Hsu, Ben
[J]. RHEUMATOLOGY, 2014, 53 : 142 - 142
[2] The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Braun, Juergen
Baraliakos, Xenofon
Hermann, Kay-Geert A.
Deodhar, Atul
van der Heijde, Desiree
Inman, Robert
Beutler, Anna
Zhou, Yiying
Xu, Stephen
Hsu, Benjamin
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1107 - 1113
[3] GOLIMUMAB, A NEW, HUMAN, TNFα ANTIBODY, IN ANKYLOSING SPONDYLITIS (AS): 24-WEEK EFFICACY AND SAFETY RESULTS OF THE GO-RAISE STUDY
Braun, Jurgen
Davis, John
van der Heijde, Desiree
Deodhar, Atul
Diekman, Laura
Sieper, Joachim
Kim, Sung Il
Han, John
Hsu, B.
Inman, Robert
[J]. RHEUMATOLOGY, 2009, 48 : I57 - I57
[4] Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Deodhar, Atul
Braun, Juergen
Inman, Robert D.
van der Heijde, Desiree
Zhou, Yiying
Xu, Stephen
Han, Chenglong
Hsu, Benjamin
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (04) : 757 - 761
[5] Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
Braun, Juergen
Baraliakos, Xenofon
Hermann, Kay-Geert A.
van der Heijde, Desiree
Inman, Robert D.
Deodhar, Atul A.
Baratelle, Anna
Xu, Stephen
Xu, Weichun
Hsu, Benjamin
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 878 - 884
[6] Golimumab significantly improves physical function in patients with active Ankylosing spondylitis: Results from the phase 3 GO-RAISE
Inman, R. D.
van der Heijde, D.
Deodhar, A.
Mack, M.
Parasuraman, S.
Buchanan, J.
Hsu, B.
Beutler, A.
Han, C.
Braun, J.
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S586 - S586
[7] Golimumab significantly improves sleep in patients with active ankylosing spondylitis: Results from the phase 3 GO-RAISE study
Deodhar, A.
Braun, J.
Inman, R. D.
Mack, M.
Parasuraman, S.
Buchanan, J.
Hsu, B.
Beutler, A.
Han, C.
van der Heijde, D.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 747 - 747
[8] Golimumab significantly improves productivity in patients with active Ankylosing spondylitis: Results from the phase 3 GO-RAISE study
Braun, J.
Inman, R. D.
van der Heijde, D.
Mack, M.
Parasuraman, S.
Buchanan, J.
Hsu, B.
Beutler, A.
Han, C.
Deodhar, A.
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S582 - S582
[9] GOLIMUMAB SIGNIFICANTLY IMPROVES PRODUCTIVITY IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM THE PHASE 3 GO-RAISE STUDY
Braun, J.
Inman, R. D.
van der Heijde, D.
Mack, M.
Parasuraman, S.
Buchanan, J.
Hsu, B.
Beutler, A.
Han, C.
Deodhar, A.
[J]. VALUE IN HEALTH, 2009, 12 (03) : A72 - A72
[10] Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)
van der Heijde, Desiree
Braun, Juergen
Deodhar, Atul
Inman, Robert D.
Xu, Stephen
Mack, Michael E.
Hsu, Benjamin
[J]. RHEUMATOLOGY, 2013, 52 (02) : 321 - 325

← 1 2 3 4 5 →